|
|
argenx SE
BRU •
Healthcare •
Biotechnology •
Quote as of 07/07/2026 17:37
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeBRU
Market Capitalization47,673 mln
Float61.96 mln
Earnings Date07/23/2026
1-Year Forecast
862
Modest upside
Relative Strength
44
/ 100
Slightly lagging
Key Fundamentals
EPS19.67
P/E41.21
ROE22.84
RPS60.49
ROIC43.51
ROA19.60
Interest Cover320
EBITDA, mln1,294
EV / EBITDA31.62
EV / EBIT31.62
Revenue, mln4,005
EV / Revenue10.22
Financial Strength
Altman Z-Score24.95
Piotroski F-Score
4
/ 9
Beneish M-Score-1.71
Price to Intrinsic Value49.37
Price to Graham Number4.08
1-Year Target Price862
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
0.1% |
52
/ 100
 |
| 1 Month |
6.42% |
82
/ 100
 |
| 2 Months |
32.5% |
89
/ 100
 |
| 6 Months |
15.5% |
70
/ 100
 |
| 1 Year |
67.33% |
95
/ 100
 |
|
| |
